Efficacy of the De Novo-Derived Antimicrobial Peptide WLBU2 against Oral Bacteria

Antimicrobial Agents and Chemotherapy
2007.0

Abstract

The efficacy of a novel synthetic antimicrobial peptide (WLBU2) was evaluated against three oral microorganisms (grown planktonically): Streptococcus gordonii, Fusobacterium nucleatum, and Porphyromonas gingivalis. WLBU2 killed all three species, with F. nucleatum being the most susceptible. WLBU2 also reduced the bacterial burden of S. gordonii and F. nucleatum biofilms.

Knowledge Graph

Similar Paper

Efficacy of the De Novo-Derived Antimicrobial Peptide WLBU2 against Oral Bacteria
Antimicrobial Agents and Chemotherapy 2007.0
Activity of an Antimicrobial Peptide Mimetic against Planktonic and Biofilm Cultures of Oral Pathogens
Antimicrobial Agents and Chemotherapy 2007.0
Resistance of Porphyromonas gingivalis ATCC 33277 to Direct Killing by Antimicrobial Peptides Is Protease Independent
Antimicrobial Agents and Chemotherapy 2008.0
Synthesis and Biological Evaluation of Novel Peptide BF2 as an Antibacterial Agent against Clinical Isolates of Vancomycin-Resistant Enterococci
Journal of Medicinal Chemistry 2014.0
Novel Broad-Spectrum Antimicrobial Peptide Derived from Anoplin and Its Activity on Bacterial Pneumonia in Mice
Journal of Medicinal Chemistry 2021.0
In Vitro Activities of the Lipopeptides Palmitoyl (Pal)-Lys-Lys-NH <sub>2</sub> and Pal-Lys-Lys Alone and in Combination with Antimicrobial Agents against Multiresistant Gram-Positive Cocci
Antimicrobial Agents and Chemotherapy 2007.0
Anti-biofilm and anti-adherence properties of novel cyclic dipeptides against oral pathogens
Bioorganic &amp; Medicinal Chemistry 2019.0
Novel zafirlukast derivatives exhibit selective antibacterial activity againstPorphyromonas gingivalis
MedChemComm 2019.0
In vitro and in vivo antibacterial evaluation and mechanistic study of ornithine based small cationic lipopeptides against antibiotic resistant clinical isolates
European Journal of Medicinal Chemistry 2014.0
Antimicrobial Susceptibilities of Peptostreptococcus anaerobius and the Newly Described Peptostreptococcus stomatis Isolated from Various Human Sources
Antimicrobial Agents and Chemotherapy 2007.0